{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:53:37Z","timestamp":1779378817411,"version":"3.53.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,6,23]],"date-time":"2012-06-23T00:00:00Z","timestamp":1340409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2012,6,23]],"date-time":"2012-06-23T00:00:00Z","timestamp":1340409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroimmune Pharmacol"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s11481-012-9382-z","type":"journal-article","created":{"date-parts":[[2012,6,22]],"date-time":"2012-06-22T23:39:12Z","timestamp":1340408352000},"page":"656-664","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Inflammation in Patients with Schizophrenia: The Therapeutic Benefits of Risperidone Plus Add-On Dextromethorphan"],"prefix":"10.1007","volume":"7","author":[{"given":"Shiou-Lan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Yu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Hsuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Heng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Hsieh","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nian-Sheng","family":"Tzeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Hui","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-See","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzung Lieh","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"San-Yuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Kuang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru-Band","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,6,23]]},"reference":[{"issue":"7","key":"9382_CR1","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.parkreldis.2005.05.006","volume":"11","author":"C Barcia","year":"2005","unstructured":"Barcia C, de Pablos V, Bautista-Hernandez V, Sanchez-Bahillo A, Bernal I, Fernandez-Villalba E, Martin J, Banon R, Fernandez-Barreiro A, Herrero MT (2005) Increased plasma levels of TNF-alpha but not of IL1-beta in MPTP-treated monkeys one year after the MPTP administration. Parkinsonism Relat Disord 11(7):435\u2013439. doi:10.1016\/j.parkreldis.2005.05.006","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"9382_CR2","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1097\/01.pec.0000148039.14588.d0","volume":"20","author":"EW Boyer","year":"2004","unstructured":"Boyer EW (2004) Dextromethorphan abuse. Pediatr Emerg Care 20(12):858\u2013863","journal-title":"Pediatr Emerg Care"},{"issue":"1\u20133","key":"9382_CR3","first-page":"1","volume":"91","author":"PF Buckley","year":"2007","unstructured":"Buckley PF, Pillai A, Evans D, Stirewalt E, Mahadik S (2007) Brain derived neurotropic factor in first-episode psychosis. Schizophr Res 91(1\u20133):1\u20135","journal-title":"Schizophr Res"},{"issue":"2","key":"9382_CR4","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.neuroscience.2006.12.019","volume":"145","author":"MA Carrasco","year":"2007","unstructured":"Carrasco MA, Castro P, Sepulveda FJ, Tapia JC, Gatica K, Davis MI, Aguayo LG (2007) Regulation of glycinergic and GABAergic synaptogenesis by brain-derived neurotrophic factor in developing spinal neurons. Neuroscience 145(2):484\u2013494","journal-title":"Neuroscience"},{"issue":"2","key":"9382_CR5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0006-8993(94)90771-4","volume":"666","author":"J Church","year":"1994","unstructured":"Church J, Sawyer D, McLarnon JG (1994) Interactions of dextromethorphan with the N-methyl-D-aspartate receptor-channel complex: single channel recordings. Brain Res 666(2):189\u2013194","journal-title":"Brain Res"},{"issue":"2","key":"9382_CR6","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.psyneuen.2008.08.020","volume":"34","author":"F Cirulli","year":"2009","unstructured":"Cirulli F, Francia N, Branchi I, Antonucci MT, Aloe L, Suomi SJ, Alleva E (2009) Changes in plasma levels of BDNF and NGF reveal a gender-selective vulnerability to early adversity in rhesus macaques. Psychoneuroendocrinology 34(2):172\u2013180. doi:10.1016\/j.psyneuen.2008.08.020","journal-title":"Psychoneuroendocrinology"},{"issue":"4","key":"9382_CR7","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1080\/09540260701486647","volume":"19","author":"B Crespo-Facorro","year":"2007","unstructured":"Crespo-Facorro B, Barbadillo L, Pelayo-Teran JM, Rodriguez-Sanchez JM (2007) Neuropsychological functioning and brain structure in schizophrenia. Int Rev Psychiatry 19(4):325\u2013336. doi:10.1080\/09540260701486647","journal-title":"Int Rev Psychiatry"},{"issue":"1\u20132","key":"9382_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0920-9964(00)00084-0","volume":"52","author":"N Durany","year":"2001","unstructured":"Durany N, Michel T, Zochling R, Boissl KW, Cruz-Sanchez FF, Riederer P, Thome J (2001) Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses. Schizophr Res 52(1\u20132):79\u201386","journal-title":"Schizophr Res"},{"issue":"5","key":"9382_CR9","first-page":"41","volume":"14","author":"J Endicott","year":"1978","unstructured":"Endicott J, Forman JB, Spitzer RL (1978) Research approaches to diagnostic classification in schizophrenia. Birth Defects Orig Artic Ser 14(5):41\u201357","journal-title":"Birth Defects Orig Artic Ser"},{"issue":"5","key":"9382_CR10","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1111\/j.1460-9568.2004.03592.x","volume":"20","author":"F Fumagalli","year":"2004","unstructured":"Fumagalli F, Bedogni F, Perez J, Racagni G, Riva MA (2004) Corticostriatal brain-derived neurotrophic factor dysregulation in adult rats following prenatal stress. Eur J Neurosci 20(5):1348\u20131354","journal-title":"Eur J Neurosci"},{"issue":"2","key":"9382_CR11","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/schbul\/sbm097","volume":"34","author":"S Galderisi","year":"2008","unstructured":"Galderisi S, Quarantelli M, Volpe U, Mucci A, Cassano GB, Invernizzi G, Rossi A, Vita A, Pini S, Cassano P, Daneluzzo E, De Peri L, Stratta P, Brunetti A, Maj M (2008) Patterns of structural MRI abnormalities in deficit and nondeficit schizophrenia. Schizophr Bull 34(2):393\u2013401. doi:10.1093\/schbul\/sbm097","journal-title":"Schizophr Bull"},{"key":"9382_CR12","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/j.1749-6632.2000.tb06192.x","volume":"899","author":"E Grunblatt","year":"2000","unstructured":"Grunblatt E, Mandel S, Youdim MB (2000) Neuroprotective strategies in Parkinson\u2019s disease using the models of 6-hydroxydopamine and MPTP. Ann N Y Acad Sci 899:262\u2013273","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"9382_CR13","first-page":"3","volume":"22","author":"K Hashimoto","year":"2002","unstructured":"Hashimoto K, Iyo M (2002) Glutamate hypothesis of schizophrenia and targets for new antipsychotic drugs. Nihon Shinkei Seishin Yakurigaku Zasshi 22(1):3\u201313","journal-title":"Nihon Shinkei Seishin Yakurigaku Zasshi"},{"issue":"7","key":"9382_CR14","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1111\/j.1399-5618.2009.00757.x","volume":"11","author":"S Hope","year":"2009","unstructured":"Hope S, Melle I, Aukrust P, Steen NE, Birkenaes AB, Lorentzen S, Agartz I, Ueland T, Andreassen OA (2009) Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor. Bipolar Disord 11(7):726\u2013734. doi:10.1111\/j.1399-5618.2009.00757.x","journal-title":"Bipolar Disord"},{"issue":"6","key":"9382_CR15","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00401-010-0667-0","volume":"119","author":"WT Hu","year":"2010","unstructured":"Hu WT, Chen-Plotkin A, Arnold SE, Grossman M, Clark CM, Shaw LM, Pickering E, Kuhn M, Chen Y, McCluskey L, Elman L, Karlawish J, Hurtig HI, Siderowf A, Lee VM, Soares H, Trojanowski JQ (2010) Novel CSF biomarkers for Alzheimer\u2019s disease and mild cognitive impairment. Acta Neuropathol 119(6):669\u2013678. doi:10.1007\/s00401-010-0667-0","journal-title":"Acta Neuropathol"},{"issue":"3","key":"9382_CR16","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1097\/01.ALC.0000117832.62901.61","volume":"28","author":"SY Huang","year":"2004","unstructured":"Huang SY, Lin WW, Ko HC, Lee JF, Wang TJ, Chou YH, Yin SJ, Lu RB (2004) Possible interaction of alcohol dehydrogenase and aldehyde dehydrogenase genes with the dopamine D2 receptor gene in anxiety-depressive alcohol dependence. Alcohol Clin Exp Res 28(3):374\u2013384","journal-title":"Alcohol Clin Exp Res"},{"issue":"6315","key":"9382_CR17","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/350230a0","volume":"350","author":"C Hyman","year":"1991","unstructured":"Hyman C, Hofer M, Barde YA, Juhasz M, Yancopoulos GD, Squinto SP, Lindsay RM (1991) BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350(6315):230\u2013232","journal-title":"Nature"},{"issue":"5","key":"9382_CR18","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/S0278-5846(03)00112-X","volume":"27","author":"S Iritani","year":"2003","unstructured":"Iritani S, Niizato K, Nawa H, Ikeda K, Emson PC (2003) Immunohistochemical study of brain-derived neurotrophic factor and its receptor, TrkB, in the hippocampal formation of schizophrenic brains. Prog Neuropsychopharmacol Biol Psychiatry 27(5):801\u2013807. doi:10.1016\/S0278-5846(03)00112-X","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"9382_CR19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0074-7742(06)78003-5","volume":"78","author":"DC Javitt","year":"2007","unstructured":"Javitt DC (2007) Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions. Int Rev Neurobiol 78:69\u2013108. doi:10.1016\/S0074-7742(06)78003-5","journal-title":"Int Rev Neurobiol"},{"issue":"3","key":"9382_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0893-133X(98)00060-8","volume":"20","author":"JD Jentsch","year":"1999","unstructured":"Jentsch JD, Roth RH (1999) The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 20(3):201\u2013225. doi:10.1016\/S0893-133X(98)00060-8","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"9382_CR21","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1523\/JNEUROSCI.06-10-03031.1986","volume":"6","author":"JE Johnson","year":"1986","unstructured":"Johnson JE, Barde YA, Schwab M, Thoenen H (1986) Brain-derived neurotrophic factor supports the survival of cultured rat retinal ganglion cells. J Neurosci 6(10):3031\u20133038","journal-title":"J Neurosci"},{"issue":"3","key":"9382_CR22","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0304-3940(02)00529-3","volume":"328","author":"F Karege","year":"2002","unstructured":"Karege F, Schwald M, Cisse M (2002) Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett 328(3):261\u2013264","journal-title":"Neurosci Lett"},{"issue":"1\u20133","key":"9382_CR23","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.schres.2007.01.019","volume":"92","author":"T Kato","year":"2007","unstructured":"Kato T, Monji A, Hashioka S, Kanba S (2007) Risperidone significantly inhibits interferon-gamma-induced microglial activation in vitro. Schizophr Res 92(1\u20133):108\u2013115. doi:10.1016\/j.schres.2007.01.019","journal-title":"Schizophr Res"},{"issue":"2","key":"9382_CR24","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13(2):261\u2013276","journal-title":"Schizophr Bull"},{"key":"9382_CR25","volume-title":"Positive and negative syndrome scale (PANSS) rating manual","author":"SR Kay","year":"1992","unstructured":"Kay SR, Opler IA, Fishbein A (1992) Positive and negative syndrome scale (PANSS) rating manual. Multihealth System, Toronto"},{"issue":"9","key":"9382_CR26","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1007\/s00702-005-0397-y","volume":"113","author":"C Laske","year":"2006","unstructured":"Laske C, Stransky E, Leyhe T, Eschweiler GW, Wittorf A, Richartz E, Bartels M, Buchkremer G, Schott K (2006) Stage-dependent BDNF serum concentrations in Alzheimer\u2019s disease. J Neural Transm 113(9):1217\u20131224","journal-title":"J Neural Transm"},{"issue":"1","key":"9382_CR27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000205518","volume":"59","author":"BH Lee","year":"2009","unstructured":"Lee BH, Kim YK (2009) Increased plasma brain-derived neurotropic factor, not nerve growth factor-Beta, in schizophrenia patients with better response to risperidone treatment. Neuropsychobiology 59(1):51\u201358. doi:10.1159\/000205518","journal-title":"Neuropsychobiology"},{"issue":"6","key":"9382_CR28","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1096\/fj.04-2555com","volume":"19","author":"G Li","year":"2005","unstructured":"Li G, Cui G, Tzeng NS, Wei SJ, Wang T, Block ML, Hong JS (2005) Femtomolar concentrations of dextromethorphan protect mesencephalic dopaminergic neurons from inflammatory damage. FASEB J 19(6):489\u2013496","journal-title":"FASEB J"},{"issue":"1","key":"9382_CR29","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1046\/j.1460-9568.2001.01633.x","volume":"14","author":"BK Lipska","year":"2001","unstructured":"Lipska BK, Khaing ZZ, Weickert CS, Weinberger DR (2001) BDNF mRNA expression in rat hippocampus and prefrontal cortex: effects of neonatal ventral hippocampal damage and antipsychotic drugs. Eur J Neurosci 14(1):135\u2013144","journal-title":"Eur J Neurosci"},{"issue":"1","key":"9382_CR30","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1124\/jpet.102.043166","volume":"305","author":"Y Liu","year":"2003","unstructured":"Liu Y, Qin L, Li G, Zhang W, An L, Liu B, Hong JS (2003) Dextromethorphan protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation. J Pharmacol Exp Ther 305(1):212\u2013218. doi:10.1124\/jpet.102.043166","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"9382_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.psychres.2008.10.024","volume":"176","author":"L Liu","year":"2010","unstructured":"Liu L, Jia F, Yuan G, Chen Z, Yao J, Li H, Fang C (2010) Tyrosine hydroxylase, interleukin-1beta and tumor necrosis factor-alpha are overexpressed in peripheral blood mononuclear cells from schizophrenia patients as determined by semi-quantitative analysis. Psychiatry Res 176(1):1\u20137. doi:10.1016\/j.psychres.2008.10.024","journal-title":"Psychiatry Res"},{"issue":"1","key":"9382_CR32","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1006\/dbio.1994.1250","volume":"165","author":"K Mizuno","year":"1994","unstructured":"Mizuno K, Carnahan J, Nawa H (1994) Brain-derived neurotrophic factor promotes differentiation of striatal GABAergic neurons. Dev Biol 165(1):243\u2013256","journal-title":"Dev Biol"},{"issue":"4","key":"9382_CR33","doi-asserted-by":"publisher","first-page":"276","DOI":"10.2174\/157015909790031210","volume":"7","author":"K Ohira","year":"2009","unstructured":"Ohira K, Hayashi M (2009) A new aspect of the TrkB signaling pathway in neural plasticity. Current neuropharmacology 7(4):276\u2013285","journal-title":"Current neuropharmacology"},{"issue":"6406","key":"9382_CR34","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/360755a0","volume":"360","author":"RW Oppenheim","year":"1992","unstructured":"Oppenheim RW, Yin QW, Prevette D, Yan Q (1992) Brain-derived neurotrophic factor rescues developing avian motoneurons from cell death. Nature 360(6406):755\u2013757","journal-title":"Nature"},{"issue":"12","key":"9382_CR35","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/S0028-3908(98)00141-5","volume":"37","author":"W Pan","year":"1998","unstructured":"Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ (1998) Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 37(12):1553\u20131561","journal-title":"Neuropharmacology"},{"issue":"12","key":"9382_CR36","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1523\/JNEUROSCI.23-12-05050.2003","volume":"23","author":"HB Peng","year":"2003","unstructured":"Peng HB, Yang JF, Dai Z, Lee CW, Hung HW, Feng ZH, Ko CP (2003) Differential effects of neurotrophins and schwann cell-derived signals on neuronal survival\/growth and synaptogenesis. J Neurosci 23(12):5050\u20135060","journal-title":"J Neurosci"},{"key":"9382_CR37","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0079-6123(07)63020-9","volume":"163","author":"M Pickering","year":"2007","unstructured":"Pickering M, O\u2019Connor JJ (2007) Pro-inflammatory cytokines and their effects in the dentate gyrus. Prog Brain Res 163:339\u2013354. doi:10.1016\/S0079-6123(07)63020-9","journal-title":"Prog Brain Res"},{"issue":"5","key":"9382_CR38","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/glia.20467","volume":"55","author":"L Qin","year":"2007","unstructured":"Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong JS, Knapp DJ, Crews FT (2007) Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 55(5):453\u2013462. doi:10.1002\/glia.20467","journal-title":"Glia"},{"issue":"6","key":"9382_CR39","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.bbi.2007.05.005","volume":"21","author":"N Quan","year":"2007","unstructured":"Quan N, Banks WA (2007) Brain-immune communication pathways. Brain Behav Immun 21(6):727\u2013735. doi:10.1016\/j.bbi.2007.05.005","journal-title":"Brain Behav Immun"},{"issue":"6","key":"9382_CR40","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.pnpbp.2004.05.038","volume":"28","author":"B Ribeiro Do Couto","year":"2004","unstructured":"Ribeiro Do Couto B, Aguilar MA, Manzanedo C, Rodriguez-Arias M, Minarro J (2004) Effects of NMDA receptor antagonists (MK-801 and memantine) on the acquisition of morphine-induced conditioned place preference in mice. Prog Neuropsychopharmacol Biol Psychiatry 28(6):1035\u20131043. doi:10.1016\/j.pnpbp.2004.05.038","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"6","key":"9382_CR41","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.brainresbull.2004.10.005","volume":"64","author":"B Ribeiro Do Couto","year":"2005","unstructured":"Ribeiro Do Couto B, Aguilar MA, Manzanedo C, Rodriguez-Arias M, Minarro J (2005) NMDA glutamate but not dopamine antagonists blocks drug-induced reinstatement of morphine place preference. Brain Res Bull 64(6):493\u2013503. doi:10.1016\/j.brainresbull.2004.10.005","journal-title":"Brain Res Bull"},{"issue":"6","key":"9382_CR42","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.biopsych.2011.11.026","volume":"71","author":"LM Rimol","year":"2012","unstructured":"Rimol LM, Nesvag R, Hagler DJ Jr, Bergmann O, Fennema-Notestine C, Hartberg CB, Haukvik UK, Lange E, Pung CJ, Server A, Melle I, Andreassen OA, Agartz I, Dale AM (2012) Cortical volume, surface area, and thickness in schizophrenia and bipolar disorder. Biol Psychiatry 71(6):552\u2013560. doi:10.1016\/j.biopsych.2011.11.026","journal-title":"Biol Psychiatry"},{"key":"9382_CR43","doi-asserted-by":"crossref","unstructured":"Rizos EN, Papadopoulou A, Laskos E, Michalopoulou PG, Kastania A, Vasilopoulos D, Katsafouros K, Lykouras L (2008) Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics. World J Biol Psychiatry:1-5","DOI":"10.1080\/15622970802182733"},{"issue":"2","key":"9382_CR44","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2147\/nedt.1.2.171.61048","volume":"1","author":"A Schmitt","year":"2005","unstructured":"Schmitt A, Bertsch T, Tost H, Bergmann A, Henning U, Klimke A, Falkai P (2005) Increased serum interleukin-1beta and interleukin-6 in elderly, chronic schizophrenic patients on stable antipsychotic medication. Neuropsychiatr Dis Treat 1(2):171\u2013177","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"6","key":"9382_CR45","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/0896-6273(92)90064-K","volume":"9","author":"RA Segal","year":"1992","unstructured":"Segal RA, Takahashi H, McKay RD (1992) Changes in neurotrophin responsiveness during the development of cerebellar granule neurons. Neuron 9(6):1041\u20131052","journal-title":"Neuron"},{"issue":"4","key":"9382_CR46","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.neubiorev.2011.12.015","volume":"36","author":"AM Shepherd","year":"2012","unstructured":"Shepherd AM, Laurens KR, Matheson SL, Carr VJ, Green MJ (2012) Systematic meta-review and quality assessment of the structural brain alterations in schizophrenia. Neurosci Biobehav Rev 36(4):1342\u20131356. doi:10.1016\/j.neubiorev.2011.12.015","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"9382_CR47","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.neulet.2003.08.004","volume":"351","author":"E Shimizu","year":"2003","unstructured":"Shimizu E, Hashimoto K, Watanabe H, Komatsu N, Okamura N, Koike K, Shinoda N, Nakazato M, Kumakiri C, Okada S, Iyo M (2003) Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls. Neurosci Lett 351(2):111\u2013114","journal-title":"Neurosci Lett"},{"issue":"7","key":"9382_CR48","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1179\/016164105X49526","volume":"27","author":"AR Simard","year":"2005","unstructured":"Simard AR, Rivest S (2005) Do pathogen exposure and innate immunity cause brain diseases? Neurol Res 27(7):717\u2013725","journal-title":"Neurol Res"},{"issue":"12","key":"9382_CR49","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/mp.2009.52","volume":"14","author":"J Soderlund","year":"2009","unstructured":"Soderlund J, Schroder J, Nordin C, Samuelsson M, Walther-Jallow L, Karlsson H, Erhardt S, Engberg G (2009) Activation of brain interleukin-1beta in schizophrenia. Mol Psychiatry 14(12):1069\u20131071. doi:10.1038\/mp.2009.52","journal-title":"Mol Psychiatry"},{"issue":"6","key":"9382_CR50","doi-asserted-by":"publisher","first-page":"100080","DOI":"10.1503\/jpn.100080","volume":"35","author":"J Soderlund","year":"2010","unstructured":"Soderlund J, Olsson SK, Samuelsson M, Walther-Jallow L, Johansson C, Erhardt S, Landen M, Engberg G (2010) Elevation of cerebrospinal fluid interleukin-1ss in bipolar disorder. Journal of Psychiatry & Neuroscience 35(6):100080. doi:10.1503\/jpn.100080","journal-title":"Journal of Psychiatry & Neuroscience"},{"issue":"6","key":"9382_CR51","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.biopsych.2008.10.018","volume":"65","author":"XQ Song","year":"2009","unstructured":"Song XQ, Lv LX, Li WQ, Hao YH, Zhao AP (2009) The interaction of nuclear factor-kappa B and cytokines is associated with schizophrenia. Biol Psychiatry 65(6):481\u2013488","journal-title":"Biol Psychiatry"},{"issue":"9","key":"9382_CR52","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1176\/appi.ajp.157.9.1475","volume":"157","author":"ER Sowell","year":"2000","unstructured":"Sowell ER, Levitt J, Thompson PM, Holmes CJ, Blanton RE, Kornsand DS, Caplan R, McCracken J, Asarnow R, Toga AW (2000) Brain abnormalities in early-onset schizophrenia spectrum disorder observed with statistical parametric mapping of structural magnetic resonance images. Am J Psychiatry 157(9):1475\u20131484","journal-title":"Am J Psychiatry"},{"issue":"2","key":"9382_CR53","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.pnpbp.2008.12.006","volume":"33","author":"H Sugino","year":"2009","unstructured":"Sugino H, Futamura T, Mitsumoto Y, Maeda K, Marunaka Y (2009) Atypical antipsychotics suppress production of proinflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide-treated mice. Prog Neuropsychopharmacol Biol Psychiatry 33(2):303\u2013307. doi:10.1016\/j.pnpbp.2008.12.006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"3","key":"9382_CR54","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/sj.mp.4000718","volume":"5","author":"M Takahashi","year":"2000","unstructured":"Takahashi M, Shirakawa O, Toyooka K, Kitamura N, Hashimoto T, Maeda K, Koizumi S, Wakabayashi K, Takahashi H, Someya T, Nawa H (2000) Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients. Mol Psychiatry 5(3):293\u2013300","journal-title":"Mol Psychiatry"},{"key":"9382_CR55","doi-asserted-by":"crossref","unstructured":"Thompson RM, Weickert CS, Wyatt E, Webster MJ (2011) Decreased BDNF, trkB-TK+ and GAD(67) mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders. J Psychiatry Neurosci 36(1). doi:10.1503\/jpn.100048","DOI":"10.1503\/jpn.100048"},{"issue":"3","key":"9382_CR56","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0165-1781(02)00127-0","volume":"110","author":"K Toyooka","year":"2002","unstructured":"Toyooka K, Asama K, Watanabe Y, Muratake T, Takahashi M, Someya T, Nawa H (2002) Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients. Psychiatry Res 110(3):249\u2013257","journal-title":"Psychiatry Res"},{"key":"9382_CR57","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0074-7742(07)82013-7","volume":"82","author":"B Viviani","year":"2007","unstructured":"Viviani B, Gardoni F, Marinovich M (2007) Cytokines and neuronal ion channels in health and disease. Int Rev Neurobiol 82:247\u2013263. doi:10.1016\/S0074-7742(07)82013-7","journal-title":"Int Rev Neurobiol"},{"issue":"3","key":"9382_CR58","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/BF01969565","volume":"7","author":"SC Wang","year":"1977","unstructured":"Wang SC, Chou DT, Wallenstein MC (1977) Studies on the potency of various antitussive agents. Agents Actions 7(3):337\u2013340","journal-title":"Agents Actions"},{"issue":"6","key":"9382_CR59","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/sj.mp.4001308","volume":"8","author":"CS Weickert","year":"2003","unstructured":"Weickert CS, Hyde TM, Lipska BK, Herman MM, Weinberger DR, Kleinman JE (2003) Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol Psychiatry 8(6):592\u2013610","journal-title":"Mol Psychiatry"},{"issue":"5","key":"9382_CR60","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.pnpbp.2007.03.010","volume":"31","author":"R Yoshimura","year":"2007","unstructured":"Yoshimura R, Hori H, Sugita A, Ueda N, Kakihara S, Umene W, Nakano Y, Shinkai K, Mitoma M, Ohta M, Shinkai T, Nakamura J (2007) Treatment with risperidone for 4\u00a0weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry 31(5):1072\u20131077. doi:10.1016\/j.pnpbp.2007.03.010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"3","key":"9382_CR61","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1096\/fj.03-0983fje03-0983fje","volume":"18","author":"W Zhang","year":"2004","unstructured":"Zhang W, Wang T, Qin L, Gao HM, Wilson B, Ali SF, Hong JS, Liu B (2004) Neuroprotective effect of dextromethorphan in the MPTP Parkinson\u2019s disease model: role of NADPH oxidase. FASEB J 18(3):589\u2013591. doi:10.1096\/fj.03-0983fje03-0983fje","journal-title":"FASEB J"},{"issue":"3","key":"9382_CR62","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1096\/fj.04-1586fje","volume":"19","author":"W Zhang","year":"2005","unstructured":"Zhang W, Qin L, Wang T, Wei SJ, Gao HM, Liu J, Wilson B, Liu B, Kim HC, Hong JS (2005) 3-hydroxymorphinan is neurotrophic to dopaminergic neurons and is also neuroprotective against LPS-induced neurotoxicity. FASEB J 19(3):395\u2013397. doi:10.1096\/fj.04-1586fje","journal-title":"FASEB J"},{"issue":"14","key":"9382_CR63","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1096\/fj.06-6006com","volume":"20","author":"W Zhang","year":"2006","unstructured":"Zhang W, Shin EJ, Wang T, Lee PH, Pang H, Wie MB, Kim WK, Kim SJ, Huang WH, Wang Y, Zhang W, Hong JS, Kim HC (2006) 3-Hydroxymorphinan, a metabolite of dextromethorphan, protects nigrostriatal pathway against MPTP-elicited damage both in vivo and in vitro. FASEB J 20(14):2496\u20132511","journal-title":"FASEB J"}],"updated-by":[{"DOI":"10.1007\/s11481-012-9389-5","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2012,7,25]],"date-time":"2012-07-25T00:00:00Z","timestamp":1343174400000}}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-012-9382-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11481-012-9382-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-012-9382-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-012-9382-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T16:39:21Z","timestamp":1733243961000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11481-012-9382-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,23]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["9382"],"URL":"https:\/\/doi.org\/10.1007\/s11481-012-9382-z","relation":{"erratum":[{"id-type":"doi","id":"10.1007\/s11481-012-9389-5","asserted-by":"object"}]},"ISSN":["1557-1890","1557-1904"],"issn-type":[{"value":"1557-1890","type":"print"},{"value":"1557-1904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,23]]},"assertion":[{"value":"17 January 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2012","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Erratum","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An Erratum to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11481-012-9389-5","URL":"https:\/\/doi.org\/10.1007\/s11481-012-9389-5","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}]}}